Matteo Monami Selected Research

RLP068

1/2020	Antimicrobial Photodynamic Therapy in Infected Diabetic Foot Ulcers: A Multicenter Preliminary Experience.
1/2014	Photodynamic topical antimicrobial therapy for infected foot ulcers in patients with diabetes: a randomized, double-blind, placebo-controlled study--the D.A.N.T.E (Diabetic ulcer Antimicrobial New Topical treatment Evaluation) study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matteo Monami Research Topics

Disease

42	Type 2 Diabetes Mellitus (MODY) 01/2022 - 08/2006
11	Heart Failure 01/2022 - 10/2008
9	Neoplasms (Cancer) 01/2019 - 11/2007
8	Obesity 10/2021 - 04/2009
8	Myocardial Infarction 01/2020 - 08/2004
7	Ulcer 12/2022 - 10/2002
7	Hypoglycemia (Reactive Hypoglycemia) 12/2021 - 10/2006
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 06/2007
6	Hyperglycemia 02/2016 - 01/2007
6	Erectile Dysfunction 12/2011 - 04/2010
5	Body Weight (Weight, Body) 01/2022 - 08/2008
5	Pancreatitis 07/2020 - 11/2011
5	Diabetes Mellitus 04/2017 - 08/2006
5	Hypogonadism (Hypergonadotropic Hypogonadism) 06/2012 - 09/2009
5	Chronic Disease (Chronic Diseases) 01/2011 - 04/2010
4	Diabetic Foot 12/2022 - 10/2002
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 12/2010
4	Weight Loss (Weight Reduction) 01/2018 - 04/2009
4	Overweight 03/2012 - 08/2006
3	Pancreatic Neoplasms (Pancreatic Cancer) 07/2020 - 01/2017
3	Peripheral Arterial Disease 07/2019 - 01/2016
3	Bone Fractures (Bone Fracture) 01/2017 - 02/2008
3	Myocardial Ischemia (Ischemic Heart Diseases) 02/2016 - 05/2008
3	Weight Gain 01/2016 - 08/2008
3	Hypertension (High Blood Pressure) 02/2011 - 01/2004
2	Infections 12/2022 - 01/2020
2	Cholelithiasis 03/2020 - 01/2017
2	Stroke (Strokes) 01/2020 - 08/2017
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019 - 02/2014
2	Chronic Limb-Threatening Ischemia 04/2017 - 01/2016
2	Foot Ulcer 01/2016 - 01/2014
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2012 - 01/2011
2	Alcoholism (Alcohol Abuse) 08/2010 - 12/2009
2	ST Elevation Myocardial Infarction 06/2008 - 05/2006
1	COVID-19 12/2021
1	Human Influenza (Influenza) 05/2021
1	Chronic Renal Insufficiency 01/2021
1	Gestational Diabetes (Gestational Diabetes Mellitus) 04/2020
1	Atrial Fibrillation 01/2020
1	Fournier Gangrene 01/2020

Drug/Important Bio-Agent (IBA)

23	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2012
15	Insulin (Novolin)FDA Link 01/2022 - 01/2004
14	omega-Chloroacetophenone (Mace)IBA 01/2021 - 04/2010
12	Pharmaceutical PreparationsIBA 01/2022 - 08/2006
11	Glucagon-Like Peptide-1 Receptor AgonistsIBA 07/2020 - 06/2009
9	Metformin (Glucophage)FDA LinkGeneric 08/2014 - 08/2006
8	Glucagon-Like Peptide-1 ReceptorIBA 07/2020 - 08/2014
8	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2020 - 05/2011
7	Liraglutide FDA Link 07/2020 - 08/2014
7	Testosterone (Sustanon)FDA Link 06/2013 - 09/2009
6	lixisenatideIBA 07/2020 - 01/2017
6	Glucagon-Like Peptide 1 (GLP 1)IBA 07/2020 - 06/2009
5	Insulin Glargine (Lantus)FDA Link 12/2021 - 08/2008
5	rGLP-1 proteinIBA 07/2020 - 01/2017
5	dulaglutideIBA 07/2020 - 01/2017
5	semaglutideIBA 07/2020 - 01/2017
5	Exenatide (Byetta)FDA Link 07/2020 - 01/2017
5	SodiumIBA 01/2020 - 01/2017
5	ThiazolidinedionesIBA 02/2014 - 02/2008
4	Blood Glucose (Blood Sugar)IBA 01/2020 - 10/2006
4	Sodium-Glucose Transporter 2 InhibitorsIBA 07/2019 - 08/2017
4	Rosiglitazone (Avandia)FDA Link 02/2014 - 07/2008
3	LipidsIBA 01/2022 - 01/2004
3	insulin degludecIBA 12/2021 - 04/2013
3	empagliflozinIBA 07/2019 - 08/2017
3	Acarbose FDA LinkGeneric 02/2016 - 12/2009
3	EnzymesIBA 08/2014 - 11/2007
2	Pioglitazone (Actos)FDA Link 01/2022 - 02/2014
2	COVID-19 VaccinesIBA 01/2022 - 05/2021
2	Isophane Insulin (NPH Insulin)FDA Link 12/2021 - 08/2008
2	CreatinineIBA 10/2021 - 09/2009
2	saxagliptin FDA Link 01/2021 - 01/2017
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2020 - 03/2012
2	RLP068IBA 01/2020 - 01/2014
2	dapagliflozinIBA 07/2019 - 08/2017
2	CanagliflozinIBA 08/2017 - 01/2017
2	IncretinsIBA 01/2017 - 11/2011
2	Alprostadil (Muse)FDA LinkGeneric 01/2016 - 12/2011
2	AndrogensIBA 06/2013 - 09/2009
2	AdipokinesIBA 02/2013 - 01/2012
2	AdiponectinIBA 12/2012 - 01/2012
2	Dobutamine FDA LinkGeneric 06/2012 - 06/2010
2	Hypoglycemic Agents (Hypoglycemics)IBA 03/2012 - 02/2008
2	Hormones (Hormone)IBA 03/2012 - 11/2011
2	Triglycerides (Triacylglycerol)IBA 02/2011 - 08/2010
2	CholesterolIBA 08/2010 - 03/2008
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2009 - 03/2008
2	BiguanidesIBA 05/2008 - 01/2004
1	Glycoside Hydrolase InhibitorsIBA 01/2022
1	VaccinesIBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2021
1	Tocopherols (Tocopherol)IBA 01/2021

Therapy/Procedure

17	Therapeutics 01/2021 - 08/2004
5	Glycemic Control 01/2021 - 08/2008
4	Surgical Amputation (Amputations) 04/2022 - 01/2016
3	Injections 01/2020 - 12/2010
2	Bariatric Surgery 01/2021 - 01/2020
2	Duration of Therapy 01/2018 - 01/2017
1	Gas Lasers 12/2022
1	Deprescriptions 12/2020